During the past decade, McLaren Cancer Institute-Northern Michigan conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 23 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 17 clinical trials were completed. i.e. 106.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McLaren Cancer Institute-Northern Michigan" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "NRG Oncology" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Cancer Institute-Northern Michigan" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "McLaren Cancer Institute-Northern Michigan" are "Invasive Breast Carcinoma" (5 trials), "Estrogen Receptor Negative" (4 trials), "HER2/Neu Negative" (4 trials), "Progesterone Receptor Negative" (4 trials) and "Recurrent Breast Carcinoma" (4 trials). Many other conditions were trialed in "McLaren Cancer Institute-Northern Michigan" in a lesser frequency.

Most popular intervention types in "McLaren Cancer Institute-Northern Michigan" are "Drug" (50 trials), "Other" (46 trials), "Radiation" (29 trials), "Biological" (25 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (26 trials), "Laboratory Biomarker Analysis" (25 trials), "Questionnaire Administration" (15 trials), "Fluorouracil" (10 trials) and "Paclitaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "McLaren Cancer Institute-Northern Michigan" are 50 trials for "All" genders, 12 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "McLaren Cancer Institute-Northern Michigan". undefined are not yet recruiting, 14 are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in McLaren Cancer Institute-Northern Michigan, 3 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in McLaren Cancer Institute-Northern Michigan, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".